ST elevation myocardial infarction anticoagulant and antithrombotic therapy: Difference between revisions

Jump to navigation Jump to search
Line 14: Line 14:


===Oral Drugs Targeting Factor Xa===
===Oral Drugs Targeting Factor Xa===
[[Rivaroxaban]]
Rivaroxaban
 
Apixaban
Apixaban
LY517717
LY517717
YM150
YM150
DU-176b
DU-176b
PRT-054021
PRT-054021



Revision as of 23:48, 21 April 2009

WikiDoc Resources for ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Articles

Most recent articles on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Most cited articles on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Review articles on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Articles on ST elevation myocardial infarction anticoagulant and antithrombotic therapy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Images of ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Photos of ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Podcasts & MP3s on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Videos on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Evidence Based Medicine

Cochrane Collaboration on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Bandolier on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

TRIP on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Clinical Trials

Ongoing Trials on ST elevation myocardial infarction anticoagulant and antithrombotic therapy at Clinical Trials.gov

Trial results on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Clinical Trials on ST elevation myocardial infarction anticoagulant and antithrombotic therapy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

NICE Guidance on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

NHS PRODIGY Guidance

FDA on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

CDC on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Books

Books on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

News

ST elevation myocardial infarction anticoagulant and antithrombotic therapy in the news

Be alerted to news on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

News trends on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Commentary

Blogs on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Definitions

Definitions of ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Patient Resources / Community

Patient resources on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Discussion groups on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Patient Handouts on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Directions to Hospitals Treating ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Risk calculators and risk factors for ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Healthcare Provider Resources

Symptoms of ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Causes & Risk Factors for ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Diagnostic studies for ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Treatment of ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Continuing Medical Education (CME)

CME Programs on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

International

ST elevation myocardial infarction anticoagulant and antithrombotic therapy en Espanol

ST elevation myocardial infarction anticoagulant and antithrombotic therapy en Francais

Business

ST elevation myocardial infarction anticoagulant and antithrombotic therapy in the Marketplace

Patents on ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Experimental / Informatics

List of terms related to ST elevation myocardial infarction anticoagulant and antithrombotic therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Sites of Action of Antithrombins

Parenteral Drugs Targeting Factor Xa

Fondaparinux

Idraparinux

Oral Drugs Targeting Factor Xa

Rivaroxaban

Apixaban

LY517717

YM150

DU-176b

PRT-054021

References

Template:SIB

Template:WH

Template:WS